Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Should a sentinel node biopsy be performed in patients with high-risk breast cancer?

Westover KD, Westover MB, Winer EP, Richardson AL, Iglehart JD, Punglia RS.

Int J Breast Cancer. 2011;2011:973245. doi: 10.4061/2011/973245. Epub 2011 Aug 10.

PMID:
22295240
[PubMed]
Free PMC Article
2.

Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.

Kamath VJ, Giuliano R, Dauway EL, Cantor A, Berman C, Ku NN, Cox CE, Reintgen DS.

Arch Surg. 2001 Jun;136(6):688-92.

PMID:
11387010
[PubMed - indexed for MEDLINE]
3.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
[PubMed - indexed for MEDLINE]
4.

The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.

Cripe MH, Beran LC, Liang WC, Sickle-Santanello BJ.

Am J Surg. 2006 Oct;192(4):484-7.

PMID:
16978955
[PubMed - indexed for MEDLINE]
5.

FDG-PET for axillary lymph node staging in primary breast cancer.

Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S97-102. Epub 2004 May 5. Review.

PMID:
15133635
[PubMed - indexed for MEDLINE]
6.

Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.

Kinoshita T, Takasugi M, Iwamoto E, Akashi-Tanaka S, Fukutomi T, Terui S.

Am J Surg. 2006 Feb;191(2):225-9.

PMID:
16442950
[PubMed - indexed for MEDLINE]
7.

Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.

Albo D, Ames FC, Hunt KK, Ross MI, Singletary SE, Kuerer HM.

Breast Cancer Res Treat. 2003 Jan;77(1):9-14.

PMID:
12602900
[PubMed - indexed for MEDLINE]
8.

The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures.

Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, Port E, Sacchini V, Sclafani L, VanZee K, Wagman R, Borgen PI, Cody HS 3rd.

Ann Surg. 2004 Sep;240(3):462-8; discussion 468-71.

PMID:
15319717
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.

McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Cerrito PB, Edwards MJ.

J Clin Oncol. 2000 Jul;18(13):2560-6.

PMID:
10893287
[PubMed - indexed for MEDLINE]
Free Article
10.

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.

Langer I, Marti WR, Guller U, Moch H, Harder F, Oertli D, Zuber M.

Ann Surg. 2005 Jan;241(1):152-8.

PMID:
15622003
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.

Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J.

Ann Surg Oncol. 2008 May;15(5):1316-21. doi: 10.1245/s10434-007-9759-z. Epub 2008 Mar 1.

PMID:
18311507
[PubMed - indexed for MEDLINE]
12.

Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.

Khan A, Sabel MS, Nees A, Diehl KM, Cimmino VM, Kleer CG, Schott AF, Hayes DF, Chang AE, Newman LA.

Ann Surg Oncol. 2005 Sep;12(9):697-704. Epub 2005 Aug 4.

PMID:
16079956
[PubMed - indexed for MEDLINE]
13.

Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.

Cantin J, Scarth H, Levine M, Hugi M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

CMAJ. 2001 Jul 24;165(2):166-73. Erratum in: CMAJ 2001 Sep 18;165(6):744.

PMID:
11501455
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.

van den Hoven I, Kuijt GP, Voogd AC, Roumen RM.

Ann Surg Oncol. 2012 Jun;19(6):1841-9. doi: 10.1245/s10434-011-2169-2. Epub 2011 Dec 30.

PMID:
22207045
[PubMed - indexed for MEDLINE]
15.

Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.

Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P, Soran A.

J Am Coll Surg. 2009 Feb;208(2):229-35. doi: 10.1016/j.jamcollsurg.2008.10.029. Epub 2008 Dec 18.

PMID:
19228534
[PubMed - indexed for MEDLINE]
16.

Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.

Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK.

Cancer. 2007 Apr 1;109(7):1255-63.

PMID:
17330229
[PubMed - indexed for MEDLINE]
Free Article
17.

A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram.

Park J, Fey JV, Naik AM, Borgen PI, Van Zee KJ, Cody HS 3rd.

Ann Surg. 2007 Mar;245(3):462-8.

PMID:
17435554
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Final results of the Department of Defense multicenter breast lymphatic mapping trial.

Shivers S, Cox C, Leight G, Beauchamp D, Blumencranz P, Ross M, Reintgen D.

Ann Surg Oncol. 2002 Apr;9(3):248-55.

PMID:
11923131
[PubMed - indexed for MEDLINE]
19.

Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.

Okamoto T, Yamazaki K, Kanbe M, Kodama H, Omi Y, Kawamata A, Suzuki R, Igari Y, Tanaka R, Iihara M, Ito Y, Sawada T, Nishikawa T, Maki M, Kusakabe K, Mitsuhashi N, Obara T.

Breast Cancer. 2005;12(3):203-10.

PMID:
16110290
[PubMed - indexed for MEDLINE]
Free Article
20.

Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.

Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK.

J Clin Oncol. 2000 Oct 15;18(20):3480-6.

PMID:
11032588
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk